Clinical trial

Multi-dimensional Signatures for Precisely Predicting the Response and Prognosis of Lung Cancer Patients

NCT04980352

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention real world treatment by doctors Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Multi-dimensional Signatures for Precisely Predicting the Response and Prognosis of Lung Cancer Patients

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-01-01

PhaseN/A

Conditions

Responseunresolved

Prognosisunresolved

Interventions

real world treatment by doctorsOTHER

Sponsors & collaborators

Union Hospital, Tongji Medical College, Huazhong University of Science and Technologylead sponsor

Renmin Hospital of Wuhan Universitycollaborator

Wuhan TongJi Hospitalcollaborator

Wuhan Universitycollaborator

Mapped research locations

WuhanHubei, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04980352 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.